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A meta-analysis was performed on 11 cohort studies of Assisted Reproductive Technologies (ART) and subsequent childhood
cancer, published up to February 2005, which reported comparable, nonoverlapping data, and then restricted to eight studies which
presented a similar research design. The overall Standardised Incidence Ratio was 1.33 (95% CI 0.62–2.85), and 0.77 (95% CI 0.41–
1.42) when the analysis was restricted to eight studies. No evidence of publication bias was observed for the overall analysis. The data
are consistent with a lack of increase in risk of childhood cancer, though the amount of data on ART and cancer is still limited; larger
multicentric studies as well as a pooled analysis on the available data are warranted.
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Since the first child was born after In Vitro Fertilisation (IVF)
in 1978, several studies have been conducted on the possible
consequences of Assisted Reproductive Technologies (ART),
which include standard IVF, Gamete Intra-Fallopian Transfer
(GIFT) and Intra-Cytoplasmatic Sperm Injection (ICSI). Most
papers on the consequences of ART concentrated on short-term
outcomes, such as perinatal mortality, multiple pregnancies,
weight at birth and malformations (reviewed in Schieve et al,
2004 and Hansen et al, 2005), while few studies have considered
the long-term effects of these techniques.
Now that several children born after ART have reached
adolescence, it is useful to study the possible long-term
consequences of this procedure, such as cancer incidence. Cases
of cancer in children born after ART have been reported (White
et al, 1990; Toren et al, 1995; Rizk et al, 2000; Cruysberg et al, 2002;
Lee et al, 2004); the hypotheses behind a possible association
between ART and cancer could be the repeated hormonal exposure
and/or the epigenetic modification of gene expression that may be
activated by the manipulation of the gametes in the laboratory;
however, the studies on this topic are scarce (De Rycke et al, 2002;
Thompson et al, 2002; Ayhan et al, 2004; Brinton et al, 2004).
We review here the cohort studies that have considered the
association between ART and cancer in children, and performed a
meta-analysis of the available data.
MATERIALS AND METHODS
Published guidelines for meta-analysis of observational studies
(Stroup et al, 2000) were followed to perform the literature search
and the analysis, and to report the results. Studies included in the
present analysis had to meet the following inclusion criteria: they
had to be cohort studies involving children born after ART (which
represents the exposure of interest), and cancer (all types) had to
be the end point. A search on Medline and Embase was performed
for articles reported up to February 2005, using combinations of
the keywords ‘IVF’, ‘ART’, ‘children’, ‘cohort’ and ‘cancer’, and
restricting the search to articles published in English.
A broad search yielded more than 2500 potentially relevant
titles. The titles and the abstracts of the papers were screened
independently by two experts, and 161 articles which contained
information on both short- and long-term health outcomes of
children born after ART were selected. Citation indices, biblio-
graphies of the articles and review papers (Brinton et al, 2004;
Schieve et al, 2004; Lightfoot et al, 2005) were also checked to
complete the search. We selected a total of 14 studies that met the
inclusion criteria for the meta-analysis. A description of the
studies is reported in Table 1.
Out of the 14 studies, five (Bergh et al, 1999; Ericson et al, 2002;
Pinborg et al, 2003, 2004a,b) were partially overlapping, therefore
only the two most recent publications, with the larger cohort were
included in the meta-analysis (Pinborg et al, 2004b for the Danish
data set, Ericson et al, 2002 for the Swedish data set). The meta-
analysis was therefore performed on 11 of the 14 data sets
(Table 2), which reported pertinent, nonoverlapping, and compar-
able data. Three studies have different designs (White et al, 1990;
Odone-Filho et al, 2002; Moll et al, 2003), but were included
since it was possible to calculate cancer incidence ratios from
the available published data; however, a sensitive analysis was
conducted by including and excluding these studies.
Statistical analysis
Two studies (Rufat et al, 1994; Pinborg et al, 2004b) did not
provide cancer incidence rates in a reference population. For the
French study (Rufat et al, 1994), the expected cases were extracted
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yfrom the literature (Bernard et al, 1993; Gembara et al, 1995). Since
the average period of follow-up of children born after ART was not
reported in the original paper by Rufat, we estimated an average
follow-up of 2.2 years, which is the mean between the minimum
and the maximum period of follow-up.
For the Danish data sets (Pinborg et al, 2003, 2004a,b) the
expected number of cases was calculated by applying the cancer
incidence rate provided by the Danish Cancer Registry for children
0–6 years and for the period 1995–1999. The average period of
follow-up used to calculate the number of expected cases was 4.1
Table 1 Cohort studies on in vitro fertilization and childhood cancer
Authors (year) Country
Number of exposed
children Follow-up Cancer results
White et al (1990) Australia 2285
a Absent Three neuroectodermal tumours
Rufat et al (1994) France 1637 Minimum follow-up: 1 year One leukaemia
Doyle et al (1998) Britain 2507 Average follow-up: 8.6 years Two unspecified cancers
Bergh et al (1999) Sweden 5586 Maximum follow-up: 13 years One ALL, one reticulosis, one upper extremities,
one peripheral nerves cancer
Bruinsma et al (2000) Australia 5249 Average follow-up: 3 years, 9
months
One brain, one connective tissue, three leukaemia,
one salivary gland cancer
Lerner-Geva et al (2000) Israel 332 710 person years 0 cancers
Klip et al (2001) Netherlands 9479 (429 after hormonal
treatment)
Average follow-up: 4.6 years Three leukemia, four unspecified cancers
Ericson et al (2002) Sweden 9056 Maximum follow-up: 13 years Three ALL, two histiocytosis, two sarcomas, two
CNS, one retinal, one hepatic carcinoma
Odone-Filho et al (2002) Brazil
b Maximum follow-up: 5 years One AML, one neuroblastoma, two rhabdo
myosarcoma
Moll et al (2003) Netherlands
c Maximum follow-up: 1 year, 2
months
Five retinoblastoma
Pinborg et al (2003) Denmark 1080 (454 twins) Maximum follow-up: 4 years One 1 ALL, one germinal cell tumour
Pinborg et al (2004a) Denmark 3393 (twins) Minimum follow-up: 1 year 0 cancers
Pinborg et al (2004b) Denmark 8523 (3393 twins) Minimum follow-up: 1 year ALL, hepatoblastoma, unspecific tumours of thorax,
heart, cerebrum
Bradbury and Jick (2004) USA 176 Maximum follow-up: 13 years 0 cancers
aCohort without a systematic follow-up.
bHypothetical cohort, assuming that approximately 2000 children were conceived after IVF during the period 1996–2000.
cHypothetical
cohort, assuming that 1–1.5% of children were conceived after IVF. ALL¼acute lymphoblastic leukaemia; CNS¼central nervous system; AML¼acute myelocytic leukaemia.
Table 2 Cohort studies included in the meta-analysis
Author (year)
Number of
exposed children Calculation of expected cases (EC)
Observed/expected
cases (N)
Standardized incidence
ratio (95%CI)
White et al (1990) 2285 No calculation in the original study. EC calculated by applying
cancer incidence rates from the original study to the IVF
cohort
3/0.13 23.08 (8.38–67.31)
Rufat et al (1994) 1637 No calculation in the original study. EC calculated by applying
published cancer incidence rates (Bernard et al, 1993;
Gembara et al, 1995) to the IVF cohort
1/0.7 1.43 (0.31–3.79)
Doyle et al (1998) 2507 Application of cumulative national cancer rates, taking into
account year of birth and length of follow-up
2/3.5 0.57 (0.07–2.06)
Bruinsma et al
(2000)
5249 Application of the Victorian cancer incidence rates, taking into
account age and length of follow-up
6/4.33 1.39 (0.62–3.09)
Lerner-Geva et al
(2000)
332 Application of specific national cancer incidence rates, taking
into account age, gender and year of diagnosis
0/1.7 0 (0–2.18)
a
Klip et al (2001) 9050
b Application of cancer incidence rates from the Eindhoven and
the Netherlands Cancer Registries, taking into account age,
gender and calendar period
6/6.78 0.88 (0.41–1.98)
Ericson et al (2002) 9056 Application of the Swedish Cancer Registry cancer incidence
rates, taking into account year of birth, maternal age, parity
and length of involuntary childlessness
11/12.5 0.88 (0.5–1.13)
Odone-Filho et al
(2002)
Around 2000 Application of annual incidence rate of cancer for children
aged 0–4 years
4/1.17 3.42 (1.42–8.76)
Moll et al (2003) Not known Application of the 1-year age-specific mortality rates from
statistics in the Netherlands
5/0.69 7.25 (3.19–17.03)
Pinborg et al
(2004a,b)
8523 No calculation in the original study. EC calculated by applying
the 0–6 years cancer incidence rates from the Danish Cancer
Registry to the IVF cohort
9/6.7 1.34 (0.71–1.78)
Bradbury and Jick
(2004)
176 No calculation in the original study. EC were calculated by
applying retinoblastoma incidence rates from the original
study to the IVF cohort
0/0.01 0 (0–7.40)
a
aThe upper confidence limit was calculated using 0.5 as observed number of cases.
bIn all, 429 children conceived after hormonal treatment, but not after ART, were excluded.
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of children (Lidegaard et al, 2005).
For the meta-analysis, the observed and expected cases from
each study were added and the overall Standardised Incidence
Ratio (SIR) was calculated as the ratio between the number of
observed and the number of expected cases. The details for the
calculation of the expected number of cases are reported for each
study in Table 2. The exact confidence interval for SIR was
obtained by using the Poisson’s distribution.
The heterogeneity across studies was analysed with the
Cochran’s test. A SIR adjusted for study was then calculated,
using either a fixed or a random-effects model, according to the
results of the Cochran’s test (Normand, 1999).
The potential for publication bias was examined by drawing a
‘funnel plot’ in which study-specific log effect estimates were
plotted against their s.e. (Sterne et al, 2000). Egger’s test was
performed to assess the symmetry of the funnel plot (Begg and
Mazumdar, 1994; Egger et al, 1997). A significant asymmetry
indicates the presence of bias, which was set in this analysis at a
P-value o0.05. The statistical analysis was performed using
STATA package, version 8.
RESULTS
Out of the 11 studies included in this meta-analysis, two were
conducted in Australia, six in Europe, one in Israel, one in USA
and one in Brasil. Eight were cohort studies, three (White et al,
1990; Odone-Filho et al, 2002; Moll et al, 2003) the last two based
on a hypothetical cohort and one based on national statistical data
without a systematic follow-up of all the children in the cohort
(White et al, 1990).The follow-up varied from about 1 to 13 years
(Table 1). None of the cohort studies reported a significant
association between ART and childhood cancer. The three studies
with a different design reported a significant increase of
neuroectodermal cancer (White et al, 1990), retinoblastoma (Moll
et al, 2003) or cancer in general (Odone-Filho et al, 2002) in
children conceived after IVF. The SIR for each study are presented
in Figure 1.
The overall assumption of homogeneity between study-specific
SIRs was rejected (P-value for Cochran’s test o0.001), even when
restricted to the eight studies with similar design (P-value for
Cochran’s test: 0.003). The lack of homogeneity seemed to be due
to two studies (Lerner-Geva et al, 2000; Bradbury and Jick, 2004),
since the SIR¼0 could strongly influence the result even though
the studies included a small number of subjects (332 and 176,
respectively). When these two studies were excluded from the
analysis, the hypothesis of homogeneity could be accepted (P-value
for Cochran’s test: 0.76).
The final cohort included 38815 subjects, with 38.21 cases of
cancer expected vs 47 observed, giving a SIR of 1.23 (95% CI 0.93–
1.37). The analysis restricted to eight studies (excluding the studies
by White, Odone-Filho and Moll, with different designs) indicates
36.22 expected cases of childhood cancer and 35 observed, giving a
SIR of 0.97 (95% CI 0.69–1.10).
The study-adjusted SIR was 1.33 (95% CI 0.62–2.85) when all
the 11 studies were included, while it was 0.77 (95% CI 0.41–1.42)
when the analysis was restricted to eight studies.
The overall analysis did not show publication bias (Egger’s test
P-value: 0.70), while there was evidence of publication bias for the
restricted analysis (eight studies, Egger’s test P-value: 0.02). When
the two studies with SIR¼0 were excluded, no evidence of
publication bias was observed (P-value for the Egger’s test: 0.40).
DISCUSSION
Studies on childhood cancer in children born after ART have been
conducted only recently, and are analysed in this paper. Overall,
no increased risk of childhood cancer was found in the present
analysis. A previous review on four of the studies included in this
meta-analysis (Lightfoot et al, 2005) provided a meta-SIR of 1.03
(95% CI 0.61–1.63).
Meta-analysis is a useful approach when studying rare diseases,
such as childhood cancer, because the pooled data set has greater
power than each individual study (Egger and Smith, 1997; Blettner
et al, 1999). However, pooling data can also have certain
limitations, (Blettner et al, 1999; Stroup et al, 2000), such as
publication bias. Although our analysis suggests overall a lack of
such bias, the number of studies included was small, and therefore
our results are not conclusive.
Another issue is that the studies in a meta-analysis may differ
considerably in quality, design, methods of data collection,
definition of the exposure and type of confounding variables. To
SIRs
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Figure 1 Study specific Standardised Incidence Ratios of cancer in children born after ART. Notes: The studies by White and Moll are represented using
the dotted X-axis scale. The upper CIs for studies by White, Odone-Filho and Bradbury are not graphically represented, and are indicated at the top of each
line.
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followed up for several years. Three studies (White et al, 1990;
Odone-Filho et al, 2002; Moll et al, 2003) presented a slightly
modified design, so we performed a sensitivity analysis by
including and excluding these studies from the metaestimates.
Our meta-analysis could not take into account the length of
follow-up as a covariate, since not all the studies included specified
it, and when they did, it appeared obvious that the follow-up
period was different from study to study.
In this analysis, we concentrated on ART and did not consider
studies of the possible negative consequences of hormones
administered to the mothers for infertility problems, some of
which have included suggestions of (nonsignificant) increases of
childhood cancer. Similarly, studies of congenital malformation in
relation to ART have not fallen within the scope of our meta-
analysis.
In conclusion, this meta-analysis does not suggest an association
between ART and childhood cancer, even though the limited
number of studies prevent a firm conclusion and a pooled analysis
would be useful.
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